Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +153.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -12.8% from the comparable as-filed period.
Research & development changed -4.9% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.